CompoAtlas

Café Latte Flavoured Plant-Based Shakeology

Natural health product licensed in Canada

Other names
Peppermint Mocha Flavoured Plant-Based Shakeology
Licence holder
Team Beachbody Canada LP
NPN or DIN-HM
80138900
Status
Active licence
Licence date
3 March 2025
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ganoderma lucidum

Source : Ganoderma lucidum - Mycélium cultivé

150 mgNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

1.5 gNot calculated
Pisum sativum

Source : Pisum sativum - Seed fibre

750 mgNot calculated
Chenopodium quinoa

Source : Chenopodium quinoa - Graine

300 mgNot calculated
Astragalus membranaceus

Source : Astragalus membranaceus - racine

250 mgNot calculated
alpha-D-Galactoside galactohydrolase

Source : Aspergillus niger - En entier

1 mgNot calculated
alpha-D-Galactoside galactohydrolase

Source : Aspergillus niger - En entier

15 FCC GalUNot calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Source : Aspergillus niger - En entier

4 mgNot calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Source : Aspergillus niger - En entier

300 FCC CUNot calculated
Grifola frondosa150 mgNot calculated
Withania somnifera

Source : Withania somnifera - racine

150 mgNot calculated
Myrciaria dubia

Source : Myrciaria dubia - fruit

250 mgNot calculated
Protéines de pois

Source : Pisum sativum - Graine

Potency : 78 % Protein

17.43 gNot calculated
bêta-D-fructofuranoside fructohydrolase

Source : Saccharomyces cerevisiae - en entier

0.5 mgNot calculated
bêta-D-fructofuranoside fructohydrolase

Source : Saccharomyces cerevisiae - en entier

50 FCC SUNot calculated
Rosa canina200 mgNot calculated
Lepidium meyenii

Source : Lepidium meyenii - racine

55 mgNot calculated

Non-medicinal ingredients

Gomme arabique (acacia), Glycosides de stéviol, Gomme de xanthane, Lécithine, Jus de canne à sucre évaporé, Mélange de concentré de tocophérols, Saveur, Feuilles de Camellia Sinensis, Poudre de cacao, Dioxyde de silicium, Huile de tournesol, Maltodextrine, Farine d'avoine, Mélange de fruits et légumes, Extrait de fruit de Siraitia Grosvenorii, Cannellier Casse, Chlorure de sodium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Portions1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Assists in the building of lean muscle tissue/mass when combined with regular weight/resistance training and a healthy balanced diet. Athletic support. Source of amino acids involved in muscle protein synthesis. Source of protein for the maintenance of good health. Source of protein which helps build and repair body tissues. Workout supplement. Source of fungal polysaccharides with immunomodulating properties. Source of alpha-linolenic acid (ALA) for the maintenance of good health. Source of essential fatty acids for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of/Provides antioxidants. Digestive enzyme(s). Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Healthy gut support. Source of Probiotics.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80138900

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Linum usitatissimum
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

  • Withania somnifera
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Lepidium meyenii
    Read the warning, when it applies and the studies cited

    Maca - Lepidium Meyenii

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 September 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line